![]() The test can be used to assess patient prognosis by measuring the baseline HIV-1 level or to monitor the effects of antiretroviral therapy by measuring changes in HIV-1 RNA levels during the course of antiretroviral treatment. Roche launches cobas 5800, a new molecular diagnostics system to expand access to testing and improve patient care 193 Roche announced the launch of the cobasĀ® 5800 System, a new molecular laboratory instrument, in countries accepting the CE mark. From Charity Hui March 8th, 2023 0 0 likes. Title: Clinical performance of the cobas 5800 for multiple respiratory pathogens detection Speaker: Dr Jonathan Hon-kwan Chen (Scientific Officer, Queen Mary Hospital) cobas 5800. This test is intended for use in conjunction with clinical presentation and other laboratory markers for the clinical management of HIV-1 infected patients. Clinical performance of the cobas 5800 for multiple respiratory pathogens detection. The test can quantitate HIV-1 RNA over the range of 20-10,000,000 copies/mL (33 to 1.67 x 10 7 International Units/mL).
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |